Eticovo is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Samsung Bioepis Co., Ltd.. The primary component is Etanercept.
| Product ID | 71202-004_d2d6f14e-fdc3-46ab-b84b-4b17d3bea8f0 |
| NDC | 71202-004 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Eticovo |
| Generic Name | Etanercept |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-10-31 |
| Marketing Category | BLA / |
| Application Number | BLA761066 |
| Labeler Name | Samsung Bioepis Co., Ltd. |
| Substance Name | ETANERCEPT |
| Active Ingredient Strength | 25 mg/.5mL |
| Pharm Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-3531 | ENBREL | etanercept |
| 50090-4490 | ENBREL | etanercept |
| 50090-4590 | ENBREL | etanercept |
| 58406-010 | ENBREL | etanercept |
| 58406-021 | ENBREL | etanercept |
| 58406-032 | ENBREL | etanercept |
| 58406-044 | ENBREL | etanercept |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ETICOVO 88250039 not registered Live/Pending |
Samsung Bioepis Co., Ltd. 2019-01-04 |